Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:51 UTC
Update Date2022-03-07 02:51:54 UTC
HMDB IDHMDB0015219
Secondary Accession Numbers
  • HMDB15219
Metabolite Identification
Common NamePrimaquine
DescriptionAn aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
Structure
Data?1582753271
Synonyms
ValueSource
6-Methoxy-8-(4-amino-1-methylbutylamino)quinolineChEBI
8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinolineChEBI
8-(4-Amino-1-methylbutylamino)-6-methoxyquinolineChEBI
Neo-quipenylChEBI
PrimachinChEBI
PrimachinumChEBI
PrimaquinChEBI
PrimaquinaChEBI
PrimaquinumChEBI
KanaprimKegg
Diphosphate, primaquineMeSH
Phosphate, primaquineMeSH
PrimacinMeSH
Primaquine diphosphateMeSH
Primaquine phosphateMeSH
Boucher and muir brand OF primaquine phosphateMeSH, HMDB
Chemical FormulaC15H21N3O
Average Molecular Weight259.3467
Monoisotopic Molecular Weight259.168462309
IUPAC NameN4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
Traditional NameN4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
CAS Registry Number90-34-6
SMILES
COC1=CC(NC(C)CCCN)=C2N=CC=CC2=C1
InChI Identifier
InChI=1S/C15H21N3O/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14/h4,6,8-11,18H,3,5,7,16H2,1-2H3
InChI KeyINDBQLZJXZLFIT-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aminoquinolines and derivatives. These are organic compounds containing an amino group attached to a quinoline ring system.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassQuinolines and derivatives
Sub ClassAminoquinolines and derivatives
Direct ParentAminoquinolines and derivatives
Alternative Parents
Substituents
  • Aminoquinoline
  • Methoxyaniline
  • Anisole
  • Alkyl aryl ether
  • Secondary aliphatic/aromatic amine
  • Pyridine
  • Benzenoid
  • Heteroaromatic compound
  • Ether
  • Azacycle
  • Secondary amine
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Organic nitrogen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Amine
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point< 25 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.056 g/LNot Available
LogP2.1Not Available
Experimental Chromatographic Properties

Experimental Collision Cross Sections

Adduct TypeData SourceCCS Value (Å2)Reference
[M+H]+Not Available161.335http://allccs.zhulab.cn/database/detail?ID=AllCCS00000982
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.056 g/LALOGPS
logP2.76ALOGPS
logP1.64ChemAxon
logS-3.7ALOGPS
pKa (Strongest Acidic)17.11ChemAxon
pKa (Strongest Basic)10.2ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area60.17 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity78.51 m³·mol⁻¹ChemAxon
Polarizability29.92 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+162.24131661259
DarkChem[M-H]-163.82531661259
DeepCCS[M+H]+164.75830932474
DeepCCS[M-H]-162.430932474
DeepCCS[M-2H]-195.29930932474
DeepCCS[M+Na]+170.85130932474
AllCCS[M+H]+163.232859911
AllCCS[M+H-H2O]+159.632859911
AllCCS[M+NH4]+166.532859911
AllCCS[M+Na]+167.432859911
AllCCS[M-H]-166.232859911
AllCCS[M+Na-2H]-166.532859911
AllCCS[M+HCOO]-166.932859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
PrimaquineCOC1=CC(NC(C)CCCN)=C2N=CC=CC2=C13296.2Standard polar33892256
PrimaquineCOC1=CC(NC(C)CCCN)=C2N=CC=CC2=C12331.7Standard non polar33892256
PrimaquineCOC1=CC(NC(C)CCCN)=C2N=CC=CC2=C12442.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Primaquine,1TMS,isomer #1COC1=CC(NC(C)CCCN[Si](C)(C)C)=C2N=CC=CC2=C12509.9Semi standard non polar33892256
Primaquine,1TMS,isomer #1COC1=CC(NC(C)CCCN[Si](C)(C)C)=C2N=CC=CC2=C12438.6Standard non polar33892256
Primaquine,1TMS,isomer #1COC1=CC(NC(C)CCCN[Si](C)(C)C)=C2N=CC=CC2=C13381.6Standard polar33892256
Primaquine,1TMS,isomer #2COC1=CC(N(C(C)CCCN)[Si](C)(C)C)=C2N=CC=CC2=C12320.4Semi standard non polar33892256
Primaquine,1TMS,isomer #2COC1=CC(N(C(C)CCCN)[Si](C)(C)C)=C2N=CC=CC2=C12448.8Standard non polar33892256
Primaquine,1TMS,isomer #2COC1=CC(N(C(C)CCCN)[Si](C)(C)C)=C2N=CC=CC2=C13354.3Standard polar33892256
Primaquine,2TMS,isomer #1COC1=CC(N(C(C)CCCN[Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C12388.6Semi standard non polar33892256
Primaquine,2TMS,isomer #1COC1=CC(N(C(C)CCCN[Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C12569.5Standard non polar33892256
Primaquine,2TMS,isomer #1COC1=CC(N(C(C)CCCN[Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C12989.2Standard polar33892256
Primaquine,2TMS,isomer #2COC1=CC(NC(C)CCCN([Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C12614.2Semi standard non polar33892256
Primaquine,2TMS,isomer #2COC1=CC(NC(C)CCCN([Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C12617.8Standard non polar33892256
Primaquine,2TMS,isomer #2COC1=CC(NC(C)CCCN([Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C13267.2Standard polar33892256
Primaquine,3TMS,isomer #1COC1=CC(N(C(C)CCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C12601.2Semi standard non polar33892256
Primaquine,3TMS,isomer #1COC1=CC(N(C(C)CCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C12702.1Standard non polar33892256
Primaquine,3TMS,isomer #1COC1=CC(N(C(C)CCCN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)=C2N=CC=CC2=C12925.7Standard polar33892256
Primaquine,1TBDMS,isomer #1COC1=CC(NC(C)CCCN[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C12743.7Semi standard non polar33892256
Primaquine,1TBDMS,isomer #1COC1=CC(NC(C)CCCN[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C12611.0Standard non polar33892256
Primaquine,1TBDMS,isomer #1COC1=CC(NC(C)CCCN[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C13418.9Standard polar33892256
Primaquine,1TBDMS,isomer #2COC1=CC(N(C(C)CCCN)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C12590.0Semi standard non polar33892256
Primaquine,1TBDMS,isomer #2COC1=CC(N(C(C)CCCN)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C12662.3Standard non polar33892256
Primaquine,1TBDMS,isomer #2COC1=CC(N(C(C)CCCN)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C13388.7Standard polar33892256
Primaquine,2TBDMS,isomer #1COC1=CC(N(C(C)CCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C12851.1Semi standard non polar33892256
Primaquine,2TBDMS,isomer #1COC1=CC(N(C(C)CCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C12940.3Standard non polar33892256
Primaquine,2TBDMS,isomer #1COC1=CC(N(C(C)CCCN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C13153.4Standard polar33892256
Primaquine,2TBDMS,isomer #2COC1=CC(NC(C)CCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C13054.0Semi standard non polar33892256
Primaquine,2TBDMS,isomer #2COC1=CC(NC(C)CCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C12954.1Standard non polar33892256
Primaquine,2TBDMS,isomer #2COC1=CC(NC(C)CCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C13345.3Standard polar33892256
Primaquine,3TBDMS,isomer #1COC1=CC(N(C(C)CCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C13270.1Semi standard non polar33892256
Primaquine,3TBDMS,isomer #1COC1=CC(N(C(C)CCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C13203.1Standard non polar33892256
Primaquine,3TBDMS,isomer #1COC1=CC(N(C(C)CCCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C2N=CC=CC2=C13163.2Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Primaquine GC-MS (Non-derivatized) - 70eV, Positivesplash10-001l-7390000000-20feb8c491df9e9e6f0d2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Primaquine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Primaquine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-qTof , Positive-QTOFsplash10-01r6-0970000000-a3b1021cda642a6141b82017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-01p6-4290000000-d5f33ea098bbcd333ccf2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-000l-9360000000-9f32d7ddbda48f0e2dc52017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-002r-9530000000-5c70a8800c55df1915e72017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-002r-9810000000-89e3b0e2b3cb4d1e92932017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-00n0-5900000000-cbe196964f610f8bf1ff2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-00o9-3900000000-6209d7be74ea608e7fc22017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QTOF , positive-QTOFsplash10-03di-0190000000-32ab0ba382901a73b1c02017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QTOF , positive-QTOFsplash10-002f-1690000000-82416f4c3f338eece1502017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QTOF , positive-QTOFsplash10-004i-0920000000-65f7b4135f0db6eee15e2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QTOF , positive-QTOFsplash10-004i-0900000000-17b7474db1209213f6892017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QTOF , positive-QTOFsplash10-001i-0900000000-b2c7e131a6a25d1158532017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine , positive-QTOFsplash10-01r6-0970000000-a3b1021cda642a6141b82017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-001i-2900000000-d3dfd1b72d458ffd07d72017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-01p6-4290000000-314f515d08e6730a1df92017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-000l-9360000000-3933ab4d9c2c3918ecce2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-002r-9530000000-65625d68f98ae8f36ea02017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine LC-ESI-QFT , positive-QTOFsplash10-002r-7910000000-6c3e274b81107c5e98eb2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Primaquine 30V, Positive-QTOFsplash10-000l-9360000000-239fc11ba8db0d498ff22021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Primaquine 10V, Positive-QTOFsplash10-03dl-0090000000-045cb60c1f5b86235b8d2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Primaquine 20V, Positive-QTOFsplash10-0296-4290000000-01a4b9c14070fa4302c32016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Primaquine 40V, Positive-QTOFsplash10-0006-9730000000-42103ce07831ca6222a52016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Primaquine 10V, Negative-QTOFsplash10-0a4i-0090000000-1af4abbe157a64d545652016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Primaquine 20V, Negative-QTOFsplash10-0a4i-1290000000-d23ff1647c1e20943a1c2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Primaquine 40V, Negative-QTOFsplash10-006x-2930000000-c2b4d4e6f2d8325f4a712016-08-03Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB01087 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB01087 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB01087
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4739
KEGG Compound IDC07627
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkPrimaquine
METLIN IDNot Available
PubChem Compound4908
PDB IDNot Available
ChEBI ID8405
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Mihaly GW, Ward SA, Edwards G, Nicholl DD, Orme ML, Breckenridge AM: Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. Br J Clin Pharmacol. 1985 Jun;19(6):745-50. [PubMed:4027117 ]
  2. Cohen RJ, Sachs JR, Wicker DJ, Conrad ME: Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam. N Engl J Med. 1968 Nov 21;279(21):1127-31. [PubMed:5686480 ]
  3. Coleman MD, Coleman NA: Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf. 1996 Jun;14(6):394-405. [PubMed:8828017 ]
  4. ALVING AS, ARNOLD J, HOCKWALD RS, CLAYMAN CB, DERN RJ, BEUTLER E, FLANAGAN CL: Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med. 1955 Aug;46(2):301-6. [PubMed:13242948 ]
  5. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ: Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg. 2006 Sep;75(3):402-15. [PubMed:16968913 ]

Enzymes

General function:
Involved in electron carrier activity
Specific function:
The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinones involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis.
Gene Name:
NQO2
Uniprot ID:
P16083
Molecular weight:
25918.4
References
  1. Graves PR, Kwiek JJ, Fadden P, Ray R, Hardeman K, Coley AM, Foley M, Haystead TA: Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol Pharmacol. 2002 Dec;62(6):1364-72. [PubMed:12435804 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide.
Gene Name:
CYP3A4
Uniprot ID:
P08684
Molecular weight:
57255.585
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Participates in the metabolism of an as-yet-unknown biologically active molecule that is a participant in eye development.
Gene Name:
CYP1B1
Uniprot ID:
Q16678
Molecular weight:
60845.33
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.
Gene Name:
CYP2D6
Uniprot ID:
P10635
Molecular weight:
55768.94
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
Gene Name:
CYP1A1
Uniprot ID:
P04798
Molecular weight:
58164.815
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin.
Gene Name:
CYP1A2
Uniprot ID:
P05177
Molecular weight:
58406.915
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]